Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study

Martín Arranz, María Dolores; García-Ramírez, Laura; Martín Arranz, Eduardo; Montero Vega, Dolores; Rueda García, José Luis; Sánchez-Azofra, María; Poza Cordón, Joaquín; Noci Belda, Jesús; Martínez-Meco, Tamara Verges; San Miguel, Paula Blanco.
Rev. esp. enferm. dig ; 115(8): 444-449, 2023. ilus, tab
Artículo en Inglés | IBECS (España) | ID: ibc-223638

Documentos relacionados

  1. Comparison of postweaning bovine respiratory disease treatment rates between non-vaccinated control beef calves and calves variably primed and boosted using commercially available bovine coronavirus vaccines.
  2. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
  3. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
  4. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
  5. A Thermostable mRNA Vaccine against COVID-19.
  6. Including 793/B type avian infectious bronchitis vaccine in 1-day-old chicken increased the protection against QX genotype.
  7. Hatchery Spray Cabinet Administration Does Not Damage Avian Coronavirus Infectious Bronchitis Virus Vaccine Based on Analysis by Electron Microscopy and Virus Titration.
  8. Ethical considerations for epidemic vaccine trials.
  9. Fungal sugars boost vaccine protection.
  10. COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responses.